Prenatal vitamins and tumors
This article was originally published in The Tan Sheet
Executive Summary
Women who take multivitamins early in their pregnancy may reduce the risk of brain tumors in their children, according to a study in the September Cancer Epidemiology Biomarkers and Prevention. "Children whose mothers took multivitamins close to the time of conception seemed less likely to suffer medulloblastoma and primitive neuroectodermal tumors of the brain," Greta Bunin, PhD, Children's Hospital of Philadelphia, et al., say. Bunin led a study comparing 315 children diagnosed with tumors before age 6 to 315 randomly chosen healthy children. "While more research remains to be done, our findings suggest that multivitamins may prevent some brain tumors as well," the authors conclude...
You may also be interested in...
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.